Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

ILB ®, a low molecular weight dextran sulphate, restores glutamate homeostasis, amino acid metabolism and neurocognitive functions in a Rat Model of severe traumatic brain injury

Tools
- Tools
+ Tools

Lazzarino, Giacomo, Di Pietro, Valentina Di, Rinaudo, Marco, Nagy, Zsuzsanna, Barnes, Nicholas M., Bruce, Lars, Signoretti, Stefano, Mangione, Renata, Saab, Miriam Wissam, Tavazzi, Barbara, Belli, Antonio, Lazzarino, Giuseppe, Amorini, Angela Maria and Logan, Ann (2022) ILB ®, a low molecular weight dextran sulphate, restores glutamate homeostasis, amino acid metabolism and neurocognitive functions in a Rat Model of severe traumatic brain injury. International Journal of Molecular Sciences, 23 (15). e8460. doi:10.3390/ijms23158460 ISSN 1422-0067.

[img]
Preview
PDF
ijms-23-08460-v3.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (3815Kb) | Preview
Official URL: https://doi.org/10.3390/ijms23158460

Request Changes to record.

Abstract

In a previous study, we found that administration of ILB®, a new low molecular weight dextran sulphate, significantly improved mitochondrial functions and energy metabolism, as well as decreased oxidative/nitrosative stress, of brain tissue of rats exposed to severe traumatic brain injury (sTBI), induced by the closed-head weight-drop model of diffused TBI. Using aliquots of deproteinized brain tissue of the same animals of this former study, we here determined the concentrations of 24 amino acids of control rats, untreated sTBI rats (sacrificed at 2 and 7 days post-injury) and sTBI rats receiving a subcutaneous ILB® administration (at the dose levels of 1, 5 and 15 mg/kg b.w.) 30 min post-impact (sacrificed at 2 and 7 days post-injury). Additionally, in a different set of experiments, new groups of control rats, untreated sTBI rats and ILB®-treated rats (administered 30 min after sTBI at the dose levels of 1 or 5 mg/kg b.w.) were studied for their neurocognitive functions (anxiety, locomotor capacities, short- and long-term memory) at 7 days after the induction of sTBI. Compared to untreated sTBI animals, ILB® significantly decreased whole brain glutamate (normalizing the glutamate/glutamine ratio), glycine, serine and g-aminobutyric acid. Furthermore, ILB® administration restored arginine metabolism (preventing nitrosative stress), levels of amino acids involved in methylation reactions (methionine, L-cystathionine, S-adenosylhomocysteine), and N-acetylaspartate homeostasis. The macroscopic evidences of the beneficial effects on brain metabolism induced by ILB® were the relevant improvement in neurocognitive functions of the group of animals treated with ILB® 5 mg/kg b.w., compared to the marked cognitive decline measured in untreated sTBI animals. These results demonstrate that ILB® administration 30 min after sTBI prevents glutamate excitotoxicity and normalizes levels of amino acids involved in crucial brain metabolic functions. The ameliorations of amino acid metabolism, mitochondrial functions and energy metabolism in ILB®-treated rats exposed to sTBI produced significant improvement in neurocognitive functions, reinforcing the concept that ILB® is a new effective therapeutic tool for the treatment of sTBI, worth being tested in the clinical setting.

Item Type: Journal Article
Subjects: Q Science > QP Physiology
R Medicine > RB Pathology
R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
SWORD Depositor: Library Publications Router
Library of Congress Subject Headings (LCSH): Brain -- Wounds and injuries , Brain -- Wounds and injuries -- Treatment, Dextran , Amino acids in human nutrition, Cognition disorders , Oxidative stress , High performance liquid chromatography, Brain -- Pathophysiology -- Animal models
Journal or Publication Title: International Journal of Molecular Sciences
Publisher: MDPI
ISSN: 1422-0067
Official Date: 30 July 2022
Dates:
DateEvent
30 July 2022Published
27 July 2022Accepted
Volume: 23
Number: 15
Article Number: e8460
DOI: 10.3390/ijms23158460
Status: Peer Reviewed
Publication Status: Published
Reuse Statement (publisher, data, author rights): ** From MDPI via Jisc Publications Router ** History: accepted 27-07-2022; pub-electronic 30-07-2022. ** Licence for this article: https://creativecommons.org/licenses/by/4.0/
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 8 September 2022
Date of first compliant Open Access: 8 September 2022
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
UNSPECIFIEDTikomed ABhttps://www.tikomed.com/
Related URLs:
  • https://creativecommons.org/licenses/by/...

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us